CI Sep 2024 360.000 call
| Previous close | 6.78 |
| Open | 6.60 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 360.00 |
| Expiry date | 2024-09-20 |
| Day's range | 6.60 - 6.78 |
| Contract range | N/A |
| Volume | |
| Open interest | 246 |
PR NewswireExpress Scripts by Evernorth Members Paid Less for Prescriptions in 2023 Despite Drug Price Increases
Express Scripts, the pharmacy benefits services business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today released research spotlighting that members with employer-provided coverage paid less at the pharmacy counter for prescription drugs in 2023 compared to the previous year. On average, members with employer-sponsored drug coverage paid $15.10 out-of-pocket for a 30-day prescription in 2023, a decrease of about 1% compared to 2022. While drug manufacturers raised prices for 60%
ZacksAre You a Value Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ZacksCompelling Reasons to Hold on to Cigna (CI) Stock for Now
Cigna (CI) remains well-poised for growth on the back of improved pharmacy revenues in its Evernorth unit. Solid cash-generating abilities also enable it to tactically deploy capital.
